NCT01921907View on ClinicalTrials.gov

Evaluation of a Topical Treatment for Actinic Keratosis

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Actinic Keratosis of Face and Scalp
Interventions
DRUG

AD17137 topical treatment

DRUG

Placebo

Trial Locations (1)

6495301

Maccabi Health Clinic, Tel Aviv

All Listed Sponsors
lead

Assuta Hospital Systems

OTHER

NCT01921907 - Evaluation of a Topical Treatment for Actinic Keratosis | Biotech Hunter | Biotech Hunter